Quick Takeaways
- Adage Capital Management, L.P. filed SCHEDULE 13G for Bright Minds Biosciences Inc. Common Shares, no par value (DRUG).
- Disclosed ownership: 5.6%.
- Date of event: 30 Sep 2025.
Adage Capital Management, L.P. - 30 Sep 2025 SCHEDULE 13G Report for Bright Minds Biosciences Inc. Common Shares, no par value (DRUG)
- Filing Manager
- Adage Capital Management, L.P.
- Reporting Manager
- Adage Capital Management, L.P.
- Symbol
- DRUG
- Shares outstanding
- 7,092,168 shares
- Disclosed Ownership
- 395,743 shares
- Ownership
- 5.6%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Nov 2025, 09:00:15 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Adage Capital Management, L.P. disclosed 5.6% ownership in Bright Minds Biosciences Inc. Common Shares, no par value (DRUG) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2025, 09:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Adage Capital Management, L.P. | 5.6% | 395,743 | 0 | 395,743 | /s/ Robert Atchinson | By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member | |
| Robert Atchinson | 5.6% | 395,743 | 0 | 395,743 | /s/ Robert Atchinson | Robert Atchinson, individually | |
| Phillip Gross | 5.6% | 395,743 | 0 | 395,743 | /s/ Phillip Gross | Phillip Gross, individually |